Sofinnova Investments, Inc. Biomarin Pharmaceutical Inc Transaction History

Sofinnova Investments, Inc.

$1.06 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $3.12 Million - $4.18 Million	-35,608 Reduced 9.02%	359,035 $34.9 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $8.08 Million - $10.9 Million	99,893 Added 33.89%	394,643 $40.8 Million
Q3 2022 Nov 08, 2022	SELL	$82.16 - $96.94 $563,206 - $664,523	-6,855 Reduced 2.27%	294,750 $25 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $8.94 Million - $10.9 Million	125,072 Added 70.85%	301,605 $25 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $6.63 Million - $8.27 Million	89,211 Added 102.16%	176,533 $13.6 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $6.26 Million - $7.99 Million	87,322 New	87,322 $7.72 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $12.3 Million - $14.9 Million	-164,545 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $6.83 Million - $8.49 Million	-94,108 Reduced 36.38%	164,545 $14.4 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $14.1 Million - $25.6 Million	195,756 Added 311.23%	258,653 $19.7 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $14.1 Million - $22 Million	-177,149 Reduced 73.8%	62,897 $7.76 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $14.4 Million - $19.5 Million	-201,826 Reduced 45.68%	240,046 $20.3 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $22.9 Million - $30.8 Million	356,976 Added 420.49%	441,872 $37.4 Million
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $5.34 Million - $6.24 Million	66,402 Added 359.05%	84,896 $7.27 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $10.3 Million - $12 Million	-122,048 Reduced 86.84%	18,494 $1.64 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $11.3 Million - $14.9 Million	140,542 New	140,542 $12 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account